Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Staphylococcus aureus Stories

2013-05-06 23:16:09

Aims to stop bacterial pathogen growth in health care settings. Ridgeland, MS (PRWEB) May 06, 2013 Bert Rubinsky, CEO of Medical Grade Innovations (MGI), is announcing he has been issued a patent by the United States Patent and Trademark Office on fabric with antimicrobial properties. The patent number is 13/207,392. The fabric, “B++” will first be used to create bactericidal incontinent pads, sheets, pillow cases, patient gowns and operating room apparel and sold to medical...

2013-05-02 12:09:49

Using a protein complex found in breast milk, researchers force drug-resistant 'superbugs' including MRSA to respond to antibiotics again A protein complex found in human breast milk can help reverse the antibiotic resistance of bacterial species that cause dangerous pneumonia and staph infections, according to new University at Buffalo research. In petri dish and animal experiments, the protein complex – called Human Alpha-lactalbumin Made Lethal to Tumor Cells (HAMLET) –...

2013-04-18 08:30:46

AUSTIN, Texas, April 18, 2013 /PRNewswire/ --Savara Pharmaceuticals announced today that the first patient has started study drug treatment in a Phase 2 clinical trial evaluating the safety and efficacy of AeroVanc for the treatment of persistent methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis (CF) patients. AeroVanc is the first inhaled antibiotic being developed to address the growing population of MRSA lung-infected CF patients. Persistent MRSA lung...

2013-04-11 13:06:33

A new broad range antibiotic, developed jointly by scientists at The Rockefeller University and Astex Pharmaceuticals, has been found to kill a wide range of bacteria, including drug-resistant Staphylococcus (MRSA) bacteria that do not respond to traditional drugs, in mice. The antibiotic, Epimerox, targets weaknesses in bacteria that have long been exploited by viruses that attack them, known as phage, and has even been shown to protect animals from fatal infection by Bacillus anthracis, the...

Antibiotic-Resistant Superbugs A Growing Global Health Threat
2013-03-11 10:06:06

Lawrence LeBlond for redOrbit.com - Your Universe Online Climate change, terrorism and cyber-crime are all issues that are a dire threat to a nation, and now Britain´s top health official says that “superbugs” should be added to that list. The danger posed by the growing number of bacteria resistant to antibiotics is as dangerous to the country as other top threats. Professor Dame Sally Davies, chief medical officer for England, warned that routine operations could...

2013-02-26 12:28:04

NIAID Initiates Clinical Trial of STEBVax, a Staphylococcal Enterotoxin B Vaccine GAITHERSBURG, Md., Feb. 26, 2013 /PRNewswire/ -- Integrated BioTherapeutics (IBT) announces the initiation of a Phase 1 clinical trial testing the safety and immunogenicity of its staphylococcal enterotoxin B vaccine "STEBVAX" in healthy adults. This trial, marking the first time a superantigen vaccine has been administered to humans, is designed to enroll 28 individuals. STEBVax is a proprietary,...

2013-02-26 08:28:51

AUSTIN, Texas, Feb. 26, 2013 /PRNewswire/ -- Savara Pharmaceuticals today announced the formation of its Clinical Advisory Board to provide clinical guidance to the company as it advances the development of its lead product, AeroVanc(TM) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) lung infection in patients with cystic fibrosis (CF). The Clinical Advisory Board is comprised of five prominent thought leaders within the cystic fibrosis and infectious disease...

MRSA Infections Soar In Nursing Homes
2013-02-12 11:50:25

Connie K. Ho for redOrbit.com — Your Universe Online A new study by researchers from the University of California, Irvine (UCI) has found a high prevalence of various strains of community-assisted methicillin-resistant Staphylococcus aureus (CA-MRSA) in nursing homes, highlighting the importance of developing more targeted interventions to help stop the spread of the dangerous bacterial infections. MRSA is a strain of the S. aureus bacteria that became resistant to the normal...

2013-02-11 10:53:15

National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, a bacterium that frequently resists traditional antibiotics. The researchers discovered a system used by S. aureus to transport toxins that are thought to contribute to severe staph infections. These toxins–called phenol-soluble modulins (PSMs)–have gained much attention in recent years, but their multitude and...

2013-02-07 08:27:14

WAYNE, Pa., Feb. 7, 2013 /PRNewswire/ -- Molecular Detection Inc. (MDI), which develops and markets Detect-Ready(®) assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced major patent advances in the US and Europe. A second core US patent has issued covering key aspects of MDI's technology platform that assesses multiple gene targets to accurately distinguish between samples containing antibiotic-sensitive and antibiotic-resistant bacteria....


Latest Staphylococcus aureus Reference Libraries

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (1 articles) »